Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193125-25-331299
Filing Date
2025-12-23
Accepted
2025-12-23 21:05:45
Documents
1
Period of Report
2025-12-20

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 12199
  Complete submission text file 0001193125-25-331299.txt   13816
Mailing Address 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET #455 EMERYVILLE CA 94608 5105052680
4D Molecular Therapeutics, Inc. (Issuer) CIK: 0001650648 (see all company filings)

EIN.: 473506994 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address
Gupta Ashoo (Reporting) CIK: 0002091461 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39782 | Film No.: 251602237